References
- Sobue T, Inoue K, Saito H, et al. Japanese guideline for gastric cancer screening. National Cancer Center Japan; 2014. Japanese.
- Terasawa T, Nishida H, Kato K, et al. Prediction of gastric cancer development by serum pepsinogen test and Helicobacter pylori seropositivity in Eastern Asians: a systematic review and meta-analysis. PLoS One. 2014;9:e109783.
- Dixon MF, Genta RM, Yardley JH, et al. Classification and grading of gastritis. The updated Sydney ystem. International workshop on the histopathology of gastritis, Houston 1994. Am J Surg Pathol. 1996;20:1161–1181.
- Kamada T, Haruma K, Inoue K, et al. Helicobacter pylori infection and endoscopic gastritis-Kyoto classification of gastritis- The Japan Society of Gastroenterology 2015;6:982–993.
- Uemura N, Sugano K, Hiraishi H, MAGIC Study Group, et al. Risk factor profiles, drug usage, and prevalence of aspirin-associated gastroduodenal injuries among high-risk cardiovascular Japanese patients: the results from the MAGIC study. J Gastroenterol. 2014;49:814–824.
- Graham DY, Genta RM. Long-term proton pump inhibitor use and gastrointestinal cancer. Curr Gastroenterol Rep. 2008;10:543–547.
- Stolte M, Bethke B, Ruhl G, et al. Omeprazole-induced pseudohypertrophy of gastric parietal cells. Z Gastroenterol. 1992;30:134–138.
- Kimura K, Takemoto T. An endoscopic recognition of the atrophic border and its significance in chronic gastritis. Endoscopy. 1969;3:87–97.
- Boda T, Ito M, Yoshihara M, et al. Advanced method for evaluation of gastric cancer risk by serum markers: Determination of true low-risk subjects for gastric neoplasm. Helicobacter. 2014;19:1–8.
- Graham JR. Gastric polyposis: onset during long term therapy with omeprazole. Med J Aust. 1992;157:287–288.
- Hongo M, Fujimoto K. Gastric Polyps Study Group. Incidence and risk factor of fundic gland polyp and hyperplastic polyp in long-term proton pump inhibitor therapy: a prospective study in Japan. J Gastroenterol. 2010;45:618–624.
- Takamura A, Ito M, Boda T, et al. High expression of gastrin receptor protein in injured mucosa of Helicobacter pylori-positive gastritis. Dig Dis Sci. 2013;58:634–640.
- Ito M, Kiso M, Masuda K, et al. Influence of proton pump inhibitor on human gastric mucosa. I to Cho. 2016;51:491–496.
- Stolte M, Sticht T, Eidt S, et al. Frequency, location, and age and sex distribution of various types of gastric polyp. Endoscopy. 1994;26:659–665.
- Helgadóttir H, Metz DC, Lund SH, et al. Study of gender differences in proton pump inhibitor dose requirements for GERD: a double-blind randomized trial. J Clin Gastroenterol. 2016.
- Krishnamurthy S, Dayal Y. Parietal cell protrusions in gastric ulcer disease. Hum Pathol. 1997;28:1126–1130.
- Hatano Y, Haruma K, Ayaki M, et al. Black spot, a novel gastric finding potentially induced by proton pump inhibitors. Intern Med. 2016;55:3079–3084.
- Vieth M, Stolte M. Fundic gland polyps are not induced by proton pump inhibitor therapy. Am J Clin Pathol. 2001;116:716–720.
- Sugawara K, Imai Y, Saito E, et al. Cases of fundic gland polyps increasing in the size during the long-term therapy with proton pump inhibitor. Gastroenterol Endos. 2009;51:1686–1691.
- Mihara M, Haruma K, Kamada T, et al. The role of endoscopic findings for the diagnosis of Helicobacter pylori infection: evaluation in a country with high prevalence of atrophic gastritis. Helicobacter. 1999;4:40–48.
- Miwata T, Quach DT, Hiyama T, et al. Interobserver and intraobserver agreement for gastric mucosa atrophy. BMC Gastroenterol. 2015;15:95.